It drives insulin resistance, which is a precursor to type 2 diabetes
Oral glucagon-like peptide-1 receptor agonists and combinations of enteropancreatic hormones as treatments for adults with type 2 diabetes: where are we now
Lancet 406 , 14841496 (2025)
The city of Boston recently announced it reached an agreement with the group that covers unionized employees and retirees to pull back on nonspecialty drugs, including GLP-1s
Paluch AE, Boyer WR, Franklin BA, Laddu D, Lobelo F, Lee DC, et al
The company also emphasizes that its work is aligned with anti-doping principles and does not endorse or support the use of investigational endocrine agents in sport or performance-enhancement settings